Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BCTX
BCTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BCTX News
BriaCell Treatment Shows Significant Efficacy in Cancer Patients
Jan 28 2026
Newsfilter
BriaCell's New Therapy Significantly Extends Survival in Breast Cancer Patients
Jan 27 2026
Newsfilter
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline
Jan 14 2026
Benzinga
Bank of America Reports Q4 Net Income of $7.6 Billion, Exceeding Expectations
Jan 14 2026
Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1%
Jan 14 2026
Benzinga
BriaCell Therapeutics Prices Public Offering at $5.59 per Unit for $30 Million
Jan 14 2026
NASDAQ.COM
BriaCell Therapeutics Prices $30 Million Offering Amid 53.75% Stock Plunge
Jan 14 2026
Benzinga
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
Jan 14 2026
Benzinga
BriaCell Therapeutics (BCTX) Prices Public Offering at $30M
Jan 14 2026
seekingalpha
BriaCell Therapeutics (BCTX) Prices Public Offering at $5.59 per Unit, Expected to Raise $30 Million
Jan 14 2026
seekingalpha
BriaCell Prices Public Offering at $5.59 per Unit, Nearly 49% Discount
Jan 14 2026
stocktwits
BriaCell Prices Public Offering at $5.59 per Unit, Raising $30 Million
Jan 14 2026
Globenewswire
BriaCell Prices Public Offering at $5.59 per Unit, Raising Approximately $30 Million
Jan 14 2026
Yahoo Finance
BriaCell Therapeutics (BCTX) Shares Surge 39% on Positive Clinical Results for Bria-OTS Immunotherapy
Jan 13 2026
NASDAQ.COM
BriaCell Therapeutics (BCTX) Reports Complete Resolution of Lung Metastasis, Shares Surge Over 50%
Jan 13 2026
stocktwits
BriaCell's Immunotherapy Shows Complete Resolution in Breast Cancer Patient, Shares Surge 50%
Jan 13 2026
NASDAQ.COM
Show More News
